MedPath

Clinical study about the intraocular tissue plasminogen activator(t-PA) injection.

Phase 2
Conditions
Diabetic retinopathy, retinal vein occlusion, macular degeneration,sub retinal hemorrhage, macular e
Registration Number
JPRN-jRCTs041180172
Lead Sponsor
Horiguchi Masayuki
Brief Summary

For diabetic retinopathy, retinal vein occlusion, and macular edema due to macular degeneration Corrected visual acuity, which is an evaluation of visual acuity, showed a significant improvement in corrected visual acuity before and 12 months after surgery. However, the foveal retinal thickness, which was anatomically evaluated, showed a decrease between preoperative and 12 months after surgery, but no significant difference was observed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
56
Inclusion Criteria

The patient who was enough explained and understand this study.
The patient who agree this study by the free will and sign consent forms.
The patient who was diagnosed adjuvant is appropriate.

Exclusion Criteria

The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath